Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis
Abstract Toxoplasma gondii is an important food and waterborne pathogen causing toxoplasmosis, a potentially severe disease in immunocompromised or congenitally infected humans. Available therapeutic agents are limited by suboptimal efficacy and frequent side effects that can lead to treatment disco...
Main Authors: | Andrés Palencia, Alexandre Bougdour, Marie‐Pierre Brenier‐Pinchart, Bastien Touquet, Rose‐Laurence Bertini, Cristina Sensi, Gabrielle Gay, Julien Vollaire, Véronique Josserand, Eric Easom, Yvonne R Freund, Hervé Pelloux, Philip J Rosenthal, Stephen Cusack, Mohamed‐Ali Hakimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2017-02-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201607370 |
Similar Items
-
Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei
by: Albina Waithaka, et al.
Published: (2022-12-01) -
Characterization of a Toxoplasma effector uncovers an alternative GSK3/β-catenin-regulatory pathway of inflammation
by: Huan He, et al.
Published: (2018-10-01) -
Toxoplasmosis during pregnancy and infancy
by: René Stricker, et al.
Published: (2009-10-01) -
HIV-1 Capsid Rapidly Induces Long-Lived CPSF6 Puncta in Non-Dividing Cells, but Similar Puncta Already Exist in Uninfected T-Cells
by: Anabel Guedán, et al.
Published: (2024-04-01) -
Evaluation of seroepidemiological toxoplasmosis in HIV/AIDS patients in the south of Brazil
by: Graciela Augusto Xavier, et al.
Published: (2013-02-01)